Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue: +8.50%
EPS: +24.6%
Free cash flow: −16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%

Follow MEDP

Alert me

Market cap: $17.8B
P/E: 34.6×
Fwd P/E: 35.8×
Dividend yield: —
F-score: 8/9
Altman Z: 8.04
Beneish M: −2.92
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medpace Holdings, Inc. (MEDP) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Medpace Holdings, Inc. (MEDP) trades at a price to free cash flow of 26.6×. Over the past ten years it has ranged from 9.6× (August 2016) to 33.2× (December 2021); the current reading is higher than 93% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MEDP/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Medpace Holdings, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MEDP/metrics/price-to-free-cash-flow">Medpace Holdings, Inc. (MEDP) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	23.8×	32.21%
FY2024	18.0×	(24.05%)
FY2023	23.7×	23.19%
FY2022	19.2×	(42.15%)
FY2021	33.2×	52.18%
FY2020	21.8×	33.08%
FY2019	16.4×	22.49%
FY2018	13.4×	(20.95%)
FY2017	16.9×	3.31%
FY2016	16.4×	67.07%

Period	Price to free cash flow	Change
Sep 2026	26.1×	23.72%
Jun 2026	21.1×	9.90%
Mar 2026	19.2×	(19.15%)
Dec 2025	23.8×	11.16%
40 more quarters	Free account

Against its own ten years

Low 9.6× High 33.2×

Ten-year median 19.1×

Current reading's percentile 93

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
ICLR ICON PLC compare	18.1×
DGX Quest Diagnostics Incorporated compare	20.3×
QGEN QIAGEN N.V. compare	23.8×
LH Labcorp Holdings Inc. compare	25.4×
MEDP Medpace Holdings, Inc.	26.6×
RVTY Revvity Inc. compare	28.2×
ILMN Illumina, Inc. compare	30.4×
CRL Charles River Laboratories International, Inc. compare	37.6×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Medpace Holdings, Inc. (MEDP) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on MEDP

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on MEDP

Stockrow Weekly